Month: March 2022
Cutting-edge GMR technology gives automakers best-in-class performance and efficiencyATS16951 & ATS16351: Allegro’s Revolutionary New GMR Camshaft and Crankshaft Sensors
Cutting-edge GMR technology gives automakers best-in-class performance and efficiency, especially for HEV engine platforms.Manchester, NH, March 15, 2022 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today announced the release of two new state-of-the-art giant magnetoresistance (GMR) crankshaft and camshaft sensors. The ATS16951 (crankshaft) and ATS16351 (camshaft) sensors are unique in the market and provide manufacturers with a single-vendor solution that’s ideal for hybrid vehicle engines, with use cases extending to two-wheelers,...
Black Dragon (BDGR) Dracos Tokens Trading on Bilaxy
Written by Customer Service on . Posted in Public Companies.
DALLAS, TX, March 15, 2022 (GLOBE NEWSWIRE) — Black Dragon Resource Companies, Inc. (OTC Pink: BDGR) (“The Company”) Is proud to announce the start of Black Dracos Tokens trading on the Bilaxy platform.
Today, Black Dragon Resources, (BDGR) successfully launched its cryptocurrency tokens to trade on the BILAXY trading platform: https://bilaxy.com/trade/BDGR_USDT
Shareholders, Investors, and all interested parties can sign up thru BDGR official “referral” portal at: https://bilaxy.com/user/register?intro=1669239 for additional benefits and trading.
“We plan to list on multiple exchanges, and Bilaxy was the first to assist in our launch with it’s self-listing option. We are up and trading, and It’s a great milestone to complete Phase 1 of the Cryptocurrency and NFT marketing and business development. We have another 12 or...
Quoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton Syndrome
Written by Customer Service on . Posted in Public Companies.
Quoin Anticipates Initiating Clinical Testing in Q2 2022
ASHBURN, Va., March 15, 2022 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for QRX003, the Company’s investigational product for Netherton Syndrome, a rare and devastating genetic disease for which there is currently no available treatment or cure.
QRX003 is a topical lotion, formulated with a proprietary delivery technology, and contains a broad-spectrum serine protease inhibitor, whose mechanism of action is intended to perform the function of a specific protein, called LEKTI....
ALR Technologies Announces Completion of Pivotal Non-Inferiority Study on the GluCurve Pet CGM
Written by Customer Service on . Posted in Public Companies.
SINGAPORE, March 15, 2022 (GLOBE NEWSWIRE) — ALR Technologies Inc. (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today announced successful results from the conclusion of the non-inferiority study conducted on the GluCurve Pet CGM which was previously announced on February 10, 2022 and February 28, 2022. GluCurve is the first of its kind Continuous Glucose Monitor (CGM) specifically for diabetic cats and dogs.
Notable findings from the study:Utilizing a chemistry analyzer as the baseline, the GluCurve Pet CGM was more accurate than the leading Blood Glucose Meter (BGM) for animals 47.8% of the time.
100% of the GluCurve Pet CGM readings paired to the chemistry analyzer reference values were within ±20%, compared to 86.9% from the animal BGM
The GluCurve Pet CGM’s average deviation from the baseline...
One Step Vending Corp. (KOSK), Enters into a Joint Venture Agreement with Foundation Farms, Corp. and Acquires 51% of E-Roots (Abbotsford), Ltd., Tapping into the 113.7 Billion Agriculture Sector
Written by Customer Service on . Posted in Public Companies.
Harrison, NY., March 15, 2022 (GLOBE NEWSWIRE) — One Step Vending Corp. (OTC: KOSK) (“KOSK” or “the Company”), a company specializing in emerging industries acquisitions with an emphasis in the self-serve vending market, enters into a JV acquisition agreement with Foundation Farms, Corp. (“FFC”) and acquires 51% of E-Roots (Abbotsford), Ltd. (“ERA”) after its signed LOI announced in the beginning of March 2022.
The JV with FFC will provide the knowledge and technical know how in order to grow, market, and sell grown produce through the purchasing or leasing of space for operations. The acquisition will have the Company own 51% of ERA to build and purchase its self-sustaining vertical organic farming systems with a divided 50/50 revenue share.
Through the JV and acquisition, the Company will now be involved in the agriculture...
The Limestone Boat Company Is Moving Its CFO Position to Tennessee
Written by Customer Service on . Posted in Public Companies.
COLLINGWOOD, Ontario, March 15, 2022 (GLOBE NEWSWIRE) — The Limestone Boat Company (the “Company”) (TSXV: BOAT, OTCQB: LMSBF) – owner and builder of Aquasport Boats, Limestone® Boats and Boca Bay Boats – has announced the appointment of Ryan Lupton as its Interim Chief Financial Officer.
With increased production in the Company’s Tennessee facility, as well as planned expansion in the coming year, the Company will be searching for a ful-time CFO to be located in Tennessee. Mr. Lupton, who has been with BDO providing finance services to the Company for the past year, has joined the Company’s team as full-time Interim CFO, until such time as a new CFO is appointed and located in Tennessee.
“We would like to thank Pete Pigott for his exceptional work and wish him the best in his future endeavors,” said Scott Hanson, Chief Executive...
Correction: TCM Group A/S: Annual report 2021
Written by Customer Service on . Posted in Public Companies.
COMPANY ANNOUNCEMENT
No. 130/2022
Correction: Minor adjustment in the Annual Report due to a missing text line in the independent auditor’s report on page 73.
Tvis, 25 February 2022
Interim report Q4 2021 (October 1 – December 31) (All figures in brackets refer to the corresponding period in 2020)
Underlying revenue growth of 8%, but earnings below expectations impacted by an unstable supply chain situation.
CEO Torben Paulin:“In Q4 we delivered an organic like-for-like growth of 8%, and reported sales grew 4.3%, which included a negative impact from the divestment of the Svane Køkkenet store in Copenhagen to our franchisee, and the merge of the e-commerce activities in kitchn.dk and Celebert. We continue to see encouraging growth rates in revenue outside Denmark, which was up 16% compared to fourth quarter last year.
We...
Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral DYRK1A inhibitor, a portfolio of novel STING inhibitors, and a next-generation kinase inhibitor platform
On track to initiate Phase 1 study for BBI-02 for the treatment of autoimmune and inflammatory diseases in Q2 2022, with SAD and MAD topline results anticipated year-end 2022
New Drug Application (NDA) submission to the U.S. FDA for sofpironium bromide gel, 15% expected in mid-2022
BOULDER, Colo., March 15, 2022 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune,...
Acerus Reports Fourth Quarter and Full Year 2021 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
TORONTO, March 15, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and twelve-month period ended December 31, 2021. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”).
Recent HighlightsTotal Natesto® prescriptions in the US rose 20% year-over-year in the fourth quarter of 2021 and, for the full year, were up approximately 28% over fiscal 2020
The rollout and acceptance of Natesto® continues to grow in the US, now benefitting from nearly complete in-person sales interaction as the pandemic subsides
After the quarter, the Company announced it had increased its secured loan facility (the “Loan Facility”) from US$25 million to...
XCPCNL Business Services Announces LOI to Acquire Centiment Capital Holdings
Written by Customer Service on . Posted in Public Companies.
Charlotte, North Carolina, March 15, 2022 (GLOBE NEWSWIRE) — XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in the consumer products industry, is excited to announce a letter of intent to acquire Centiment Capital Holdings.
Centiment Capital is the world’s first neurotech-enabled, for-profit, anti-bias-driven machine learning company. Centiment is built on understanding neuro-data-driven problems in artificial intelligence and utilizing neuroscience-driven tools, technology and apparatus to solve them.
“We are excited about the opportunity to build shareholder value and enhance the current portfolio of Centiment Capital. We look forward to building additional revenue models with the assets we seek take over. Centiment is currently valued...
